Newsroom Articles

In celebration of Brett Monia, Ph.D., recipient of the 2025 Oligonucleotide Therapeutics Society (OTS) Lifetime Achievement Award, colleagues and peers reflect on his extraordinary impact on science, leadership and patient care.

Hear Dr. Sam Tsimikas, SVP of Global Cardiovascular Development, share how Ionis is redefining cardiometabolic care.

Endpoints News honors Ionis’ Holly Kordasiewicz, Ph.D., SVP, Neurology for her leadership, scientific impact and commitment to advancing diversity in biopharma

Championing an investigational medicine to make a meaningful difference in the lives of those living with HAE

Ionis is proud to announce that we have ranked #6 on the San Diego Business Journal’s 2025 Best Places to Work list in the Large Companies category. This marks our second consecutive year being recognized and our first year breaking into the Top 10…

Each year, the Family Heart Foundation, a patient-advocacy organization dedicated to increasing early diagnosis and treatment of lipoprotein(a) and familial hypercholesterolemia, recognizes individuals whose contributions have reshaped…

Ionis CEO Brett Monia, Ph.D. shares the journey to becoming a fully integrated biotech, advancing RNA-targeted medicines and delivering greater impact for patients.